Mammalian cell expression system is a complex glycosylation protein expression system, transient expression in mammalian cells is especially crucial when post-translational modifications and appropriate protein folding is desired for downstream applications. It is most widely used in the development and production of recombinant protein drugs, especially for therapeutic recombinant monoclonal antibody.Gene Universal’s mammalian expression services offer rapid production and delivery of high quality proteins and recombinant antibodies (rAbs) from microgram to gram quantities in either CHO or HEK293 cells, with guaranteed protein amount and purity. We use the proprietary transient mammalian expression technology to modify cellular pathways to achieve optimal protein and antibody yields (up to 3 g/L).Our guaranteed mammalian protein expression packages start with gene synthesis and sub cloning, all the way through protein expression and purification using our proprietary mammalian protein expression & purification technologies.
|No.||Service Type||Working day|
|1||20 mL Expi 293/CHO system expression and purification (Prepare endotoxin-free plasmids, Transfection,Expression and purification)||16|
|2||100 mL Expi 293/CHO system expression and purification (Prepare endotoxin-free plasmids, Transfection,Expression and purification)||20|
|3||1-50 L Expi 293/CHO system expression and purification (Prepare endotoxin-free plasmids, Transfection,Expression and purification)||Inquire|
*Package applicable for secreted proteins and extracellular domain (ECD) of membrane proteins ≤150kDa.
*QC data: SDS-PAGE will be performed to determine protein purity. BCA or Bradford assay will be used to measure protein concentration and A280 will be used to measure antibody fragment concentration.
Or download and fill out the order form below and email to email@example.com. Our sales representative will contact you within 24 hours.
Gene Universal Inc.
Address: 200 Continental Dr. Suite 401, office 402, Newark DE 19713
Copyright © 2017 Gene Universal, Inc.